The aim of this work was to evaluate whether pulse pressure (PP) in elderly people is a better predictor of coronary mortality than systolic and diastolic blood pressure taken alone. For this aim, 3282 elderly subjects aged у65 years were studied in a population-based frame. Blood pressure was repeatedly measured and averaged; historical data, anthropometrics, blood tests and 14-year coronary mortality were recorded. Statistics included analysis of covariance, Cox analysis and bivariate vectorial analysis. Coronary mortality in women was predicted by PP (1.01 excess risk/mm Hg PP) and was significantly higher in the 3rd than in the 1st tertile of PP (relative risk 2.90); neither systolic nor diastolic pressure taken alone influenced mortality. When systolic and diastolic pressures were both entered into a Cox model, the former had a positive and
Introduction
Both cross-sectional 1 and longitudinal 2 epidemiological studies have shown that systolic blood pressure (SBP) is a good predictor of cardiovascular mortality, and systolic hypertension an important cardiovascular risk factor. In the last few years, the pulsatile component of arterial BP also came into the limelight. Pulse pressure (PP), defined as the difference between SBP and diastolic BP (DBP), is usually employed to explore this component. In many studies, [3] [4] [5] [6] [7] [8] [9] subjects with higher PP were found to have a higher risk than subjects with lower PP values at the same age. Some of these studies, nevertheless, took into consideration hypertensive patients 10, 11 or groups of subjects 12 rather than people from the general population, and the role of gender was often neglected. although a disproportionate increase in SBP over DBP (high PP) is typically related to growing old, 14 elderly subjects aged 65 years or over were only marginally taken into account. 6 This study was aimed at evaluating the role of PP as a coronary risk factor in elderly men and women. In particular we wanted to clarify: (1) whether or not PP is an independent coronary risk factor for males and females, (2) whether its preditive role-if if any-depends mainly on SBP or DBP values, and (3) whether it is superior to that of SBP or DBP taken separately.
The CArdiovascular STudy in the ELderly (CASTEL) appears to be perfect for this aim, as it is large, population-based and carefully done, and includes both women and men.
Subjects and methods

Study population
The protocol of the CASTEL study has been previously published. 15 Briefly, 3282 elderly subjects aged 65 to 95 years (1381 men aged 73.1 ± 4.9 years and 2001 women aged 74.2 ± 5.5 years, P Ͻ 0.0001), reflecting the general Italian population of elderly people, were examined in the frame of a populationbased prospective study. Analysis of the putative predictive effect of components of BP on mortality was from the beginning the main aim of the study. All elderly subjects living in the northern Italian towns of Castelfranco Veneto and Chioggia were called from the Registery Office; 73% of them agreed with the study protocol, gave informed consent and were recruited, while the remaining 27% did not answer or did not accept the study protocol (the two groups were of similar age and gender). The CAS-TEL, which was started 14 years ago, has been used up to this time to demonstrate the feasibility of a longitudinal prospective study based on an elderly general population, 15 to define the role of cardiovascular risk factors in the elderly, [16] [17] [18] [19] and to analyse the effects of special care on cardiovascular survival. 20, 21 The study lasted 14 years and was carried out in accordance with the Declaration of Helsinki and approved by the CASTEL Ethics Committee. The procedures followed were in accordance with institutional guidelines.
Data collection
At the initial screening, sphygmomanometric supine BP and heart rate were measured in triplicate at 15-min intervals by trained doctors and this procedure was repeated three times at 1-month intervals; the average of the last two of the nine measurements (diastolic phase 5) was taken into consideration for the analysis of data in order to reduce the white-coat effect, if any. PP was calculated as the difference between SBP and DBP.
Historical data were recorded by means of a Rose's questionnaire. Body mass index was calculated as weight (kg)/squared height (m 2 ) ratio. A random morning urine sample was used to test albuminuria. Forced expiratory volume in 1 second was measured, and subjects having values Ͻ70% of individual theoretical reference values calculated according to Cherniack and Raber 23 were labelled as having ventilatory insufficiency.
Subjects with frank diabetes (fasting blood glucose repeatedly Ͼ7 mmol/l or history of diabetes or treatment with antidiabetic drugs) and those with prediabetic glucose intolerance (blood glucose between 6.1 and 7 mmol/l without treatment) 24 were considered together, as in a previous analysis that was carried out in the same population showed comparable cardiovascular risk. 17 All subjects underwent a two-dimensional-guided M-mode echocardiogram with a Hewlett-Packard device. Left ventricular end-diastolic diameter (EDD), end-diastolic septum (EDS) thickness, and end-diastolic posterior wall (EDPW) thickness were measured from leading edge to leading edge. 25 Mmode recordings were obtained from the apical short-axis view taking the smallest internal diameter and wall thickness; long-axis views were also employed when necessary, taking the largest internal diameter and the smallest wall thickness. 25 Recordings were automatically analysed during the examination using inner software, and simultaneously printed on photographic paper and analysed separately by another independent operator who did not know the aim and design of the study. 
Mortality data
Mortality was monitored according to the records at the Registery Office (which in Italy provides accurate data) and double-checked for causes of death by referring to hospitals, retirement homes or physicians' files. Deaths due to myocardial infarction or unambiguous fatal angina pectoris were defined as coronary artery disease (CAD) mortality.
Statistical analysis
Descriptive analysis: Analysis of variance was used to compare grouped continuous variables expressed as mean (standard error), and the Pearson's 2 test to compare frequencies of categorical variables. Age, body mass index, smoking habits and alcohol consumption being different in some of the considered groups, the analysis was adjusted for such confounders when proper.
Univariate analysis of mortality: Mortality was expressed as percent rate at the 14th year of followup. Univariate cumulative mortality curves were also generated and the Kaplan-Meyer method applied. The number of men (1281) and even more that of women (2001) was large enough to assure that no type-2 error due to low numerosity was possible.
Multivariate analysis of mortality -role of gender:
A standard Cox proportional hazards regression univariate model including as independent variables SBP or DBP or PP in both genders and in all subjects together was first performed; then a bivariate model including both SBP and DBP. Finally, secondary analyses examining the effect of antecedent CAD (ie, after excluding the 1008 subjects with clinical history of CAD) and of antihypertensive therapy was performed.
The interaction sex × PP was also included in Cox analysis. As gender and its interaction with PP were significant-indicating that PP had a different impact on survival in males and females-the multivariate model was repeated (including the same 613 variables listed above, but sex) in the two genders separately.
Multivariate analysis of mortality -role of PP:
After PP indicated a prediction of CAD mortality (see below), a special analysis in relation to this item was performed. As cut-off values for PP were not available in the literature, subjects were divided into tertiles of PP (men: 427 subjects each; women: 667 subjects each). Tertiles of systolic and diastolic BP were also generated for comparison. CAD mortality in the different tertiles was compared with the Kaplan-Meyer approach. The analysis of CAD mortality was then repeated after excluding the 1008 subjects with a clinical history of CAD.
As PP at initial screening was higher in females than in males in each tertile (see below), possibly influencing comparison of mortality by PP in the two genders, the analysis of mortality was also repeated after applying to males the values defining women's PP tertiles.
For each tertile of PP, SBP and DBP, the relative risk (RR) adjusted for possible confounders with 95% confidence intervals (95% CI) was calculated for each gender (1st tertile as reference). The analysis was first performed with PP alone, then with SBP and with DBP alone, in order to elucidate the prognostic role of these three items. Subsequently it was repeated including both SBP and DBP (the two PP components) in the same model, according to the Framingham model. 27 As 72% of men and 75% of women received antihypertensive medication, and all the subjects with CAD received antianginal medication, possibly influencing the outcome, 'antihypertensive therapy' and 'antianginal therapy' as dichotomic covariates were also included in the multivariate Cox analysis in order to adjust the results for these items.
In addition to PP (which is the difference of two correlated random variables), we also evaluated the bivariate distribution of SBP and DBP considered together as a bivariate Gaussian random vector (BP vector {SBP,DBP͖). The 95% confidence ellipses of the mean BP vectors for different groups were calculated according to formulas in the Appendix. Statistical testing for significance between mean BP vectors was performed with Hotelling T 2 test.
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Results
Analysis on the entire population
During the 14 years of follow-up there were 1615 all-cause deaths, ie, 716 in males (rate 56%) and 899 in females (rate 45%); 61 deaths in men and 90 in women were attributable to CAD. When the entire population was taken into account, four items (age, uric acid, diabetes, and historical CAD) resulted to be independent predictors for CAD mortality (Table 1) . SBP, DBP and PP as continuous items were rejected from the Cox equation.
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Males and females differed significantly in age, body mass index, SBP, DBP, PP, mean BP, heart rate, serum cholesterol, triglycerides, HDL-cholesterol, glucose and uric acid, FEV 1 and ethanol consumption. Smoking habits and prevalence of arterial hypertension, hypercholesterolaemia (Ͼ200 mg/dl), hypertriglyceridaemia (Ͼ150 mg/dl), diabetes mellitus, proteinuria, murmurs at neck, historical CAD and historical heart failure were also found to be different in males and females ( Table 2 ). The two genders were therefore analysed separately.
Gender-specific analysis
Women: When Cox regression was applied to women, five items showed to be independent predictors of CAD mortality (Table 3) : age, diabetes, serum uric acid, serum triglycerides, PP and historical CAD. The CAD risk increase was 1.01 for each mm Hg increase in PP.
SBP and DBP taken alone did not predict CAD mortality in women. When SBP and DBP were both included and forced to stay in the Cox analysis, an opposite effect of SBP and DBP on survival was demonstrated, as the coefficient of the former was positive (␤ = −0.150) and that of the latter mildly negative (␤ = −0.002).
After generating tertiles of PP, 14-year CAd mortality was 2.7% (18 deaths) in the 1st tertile, 4.6% (31 deaths) in the 2nd, and 5.7% (41 deaths) in the 3rd (P Ͻ 0.001 vs 1st). The characteristics of women in the three tertiles of PP are shown in Table 4 .
On the contrary, CAD mortality rates ( Figure 1 ) and their RR ( Figure 2) were not different in the tertiles of SBP and DBP. Furthermore, for any given tertile of SBP, CAD mortality significantly decreased with increasing DBP (Figure 3) .
When SBP and DBP were analysed together with bivariate vector analysis, the 95% confidence ellipse of the ͕DBP,SBP͖ mean vector obtained from the women who were found to have died at the end of the follow-up did not overlap with the ellipse obtained from those who were still alive ( Figure 4 , right panel), indicating a significant difference in BP vector distribution. Non-surviving women, as compared with surviving, were displaced towards higher SBP and lower DBP values (arrow in Figure  4) .
After excluding the women with CAD at the initial screening from the analysis, coronary mortality was approximately halved, but its trend in relation to PP, SBP and DBP was the same, and a significantly higher CAD mortality was only observed in those women who were in the 3rd tertile of PP (data not shown).
Men: Among men, PP, SBP and DBP as continuous items were rejected from the Cox equation of CAD mortality risk (Table 5) . Furthermore, 95% confidence ellipses of SBP,DBP͖ from dead and surviving men were overlapping (Figure 4 , left panel), indicating no role for such items in determining CAD mortality risk. After excluding the men with CAD at the initial screening from the analysis, CAD mortality was lower but the trend was of the same order (data not shown).
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Discussion
SBP and DBP unpredictive of CAD mortality
In all the CASTEL analyses, SBP and DBP taken alone, as well as systolic and diastolic hypertension, never had any predictive role on CAD mortality, either in men or in women. This is not the first notation in this respect in the elderly. Pekkanen et al 29 studying 1619 men aged 40-59 years at baseline, found that SBP was no longer associated with CAD risk after 20 years of follow-up, when subjects had become elderly, and the Framingham study in a recent re-analysis, 30 concluded that CAD mortality does not depend on SBP in a linearly increasing manner. In the recent analysis of Alli et al, 31 DBP was not an indicator of mortality risk in the elderly. This is also in agreement with previous observations [32] [33] [34] [35] [36] suggesting a limited effect of antihypertensive treatment in the prevention of CAD in elderly people. 
PP is a good predictor of CAD mortality in women
Contrary to SBP and DBP, PP appeared to be a predictor of CAD mortality, at least in women.
As in the MRC, 37 this effect was independent and graded, and was maintained after adjustment for confounders. There was an excess mortality of 1.01 for every mm Hg of PP, and in subjects having PP Ͼ80 mm Hg (those with 'pulse hypertension') RR was triplicated.
This result was not influenced by the high preva- Journal of Human Hypertension lence of CAD which is typical of any elderly population; in fact, after excluding from the analysis the subjects having CAD at the initial screening, CAD mortality, although lower, had the same trend. High PP can derive from high SBP or from low DBP, but Figures 2 and 4 show that in our experience its prognostic role in women was strongest when both these conditions were present. This was particularly evident in Figure 4 , where the vector of 14-year CAD death (arrow) was directed towards high values of SBP and low values of DBP. The opposite trend of the ␤ coefficients (positive for SBP, negative for DBP) in the Cox analysis (also recently found by other authors) 24, 37 is in keeping with this hypothesis. Other authors found that PP was a stronger predictor of CAD events than SBP, 38 DBP 38 or mean BP. 39 In contrast, in the Cardiovascular Health Study, SBP appeared to be a better predictor of CAD mortality than PP. 40 However, the follow-up of this study was shorter than that of the CASTEL (7 vs 14 years), so that the results are not directly comparable.
The pathophysiological mechanisms underlying the prognostic effect of PP may reside in that CAD risk is strictly related to the pulsatile stress caused by large-artery stiffening during systole. Stiffening has two consequences: (1) it increases SBP (which in turn increases left ventricular afterload and mass), and (2) it lowers DBP (resulting in decreased 'coronary artery driving pressure' and coronary perfusion). 41 In this study, left ventricular mass was actually higher in subjects having the highest values of SBP, requiring more perfusion during diastole. It is therefore not surprising that high SBP and low DBP (high PP) was an additional result in determining coronary risk.
PP better than SBP in predicting CAD risk: the 'true systolic' hypothesis
There is another possible explanation for the prognostic superiority of PP in comparison to SBP. In the left ventricle, BP is near to zero during diastole; consequently, the pressure recorded at the apex of systole (in other words, the pressure that is added by the systolic contraction) is really 'systolic' ( Figure 5) . This is not the case in the arterial tree; in fact, downstream from the efflux tract, BP does not reach zero during diastole, but stops at a level which is called 'DBP'. In the peripheral dictrict (for example in the brachial artery, where clinical BP is measured), the pressure that is added by the systole is therefore PP (SBP minus DBP, indicated by PP in Figure 5 ). Consequently in the arterial vessels PP indicates the systolic energy, while SBP is nothing more than a sum of two random variables (PP + DBP in Figure 5 ). If we accept that systolic work plays a role in coronary risk, PP must be (and in our experience actually is) a better risk indicator than PP + DBP. In a way we could say that PP is the 'true' systolic BP.
Why only in women?
It sounds a little strange that in the CASTEL study the effect of PP on CAD risk found expression in females and not in males.
Three hypotheses must be rejected, ie that this depends: (1) on the greater PP values observed in women at the initial screening (as grouping men with PP values comparable to those of the three women's tertiles did not produce any significant trend of coronary mortality in men), (2) on the greater prevalence of CAD in females than in males (as the difference was still present after exclusion of subjects with CAD at baseline), or (3) on the greater number of subjects in the female group than in the male group (as, when all subjects were cumulated and the Cox analysis was performed on the entire population, no prognostic role for PP or SBP was found despite the higher number of subjects; the prognostic effect of PP, evident in women, became diluted by the presence of men). A similar trend was observed for total cholesterol, whose prognostic value-present in men-was no longer present in the entire population, being diluted by the presence of women.
A possible explanation is that men and women have a different cardiovascular risk pattern, 42 and this difference increases with increasing age. 43 Arterial stiffness-reflected by PP-occurs at a later age in women than in men. 42 Consequently, enrolling women and men of the same age, we actually selected females who were biologically younger than males, with a 'younger and more compliant' arterial tree. Probably the men prone to suffer the deleterious effect of high PP had already died by the time the study was initiated, leaving to our observating a selected cohort of surviving men. 44 The demonstration of a strong predictive role for PP in women but not in men can be disturbing, as it collides with the results of recent studies 36, 41 showing a relationship between PP and cardiovascular mortality in males. These studies were not population-based, however, and no comparison with females was provided; furthermore, cardiovascular not coronary mortality was taken into consideration, and-at least in one case-the range of age was wide (20 to 82 years). Consequently, they cannot be compared with the present study that was conceived for an elderly general population of men and women.
Conclusions
Our findings suggest that the special combination of SBP and DBP that is called PP, differently from SBP and DBP taken alone, is an independent predictor of CAD mortality in elderly women, although not in men. High SBP requires low DBP to become predictive of mortality. PP measurement may therefore be of help when evaluating the individual risk and then making therapeutic decisions. Basically, most antihypertensive drugs reduce BP by reducing vascular resistance; the results presented here are probably destined to stimulate the search for drugs fit for reducing PP.
